Wall Street Zen Upgrades United States Antimony (NYSE:UAMY) to "Sell"

United States Antimony (NYSE:UAMY - Get Free Report) was upgraded by stock analysts at Wall Street Zen from a "strong sell" rating to a "sell" rating in a note issued to investors on Saturday, Wall Street Zen reports.

A number of other equities research analysts have also recently issued reports on UAMY. Weiss Ratings restated a "sell (d-)" rating on shares of United States Antimony in a report on Monday, September 14th. HC Wainwright dropped their price objective on United States Antimony from $9.25 to $6.50 and set a "buy" rating on the stock in a research note on Friday. Finally, Texas Capital upgraded United States Antimony to a "strong-buy" rating in a research note on Wednesday, October 7th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, United States Antimony presently has an average rating of "Moderate Buy" and an average price target of $8.75.

United States Antimony Stock Up 7.3%

NYSE UAMY opened at $3.12 on Friday. The company has a fifty day simple moving average of $3.77 and a 200 day simple moving average of $6.89. United States Antimony has a 1 year low of $2.53 and a 1 year high of $12.64.

United States Antimony (NYSE:UAMY - Get Free Report) last posted its earnings results on Thursday, November 12th. The company reported ($0.06) earnings per share (EPS) for the quarter. The firm had revenue of $10.13 million during the quarter. United States Antimony had a negative net margin of 55.44% and a negative return on equity of 7.73%. On average, sell-side analysts expect that United States Antimony will post -0.01 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Joseph A. Carrabba bought 21,300 shares of the company's stock in a transaction that occurred on Tuesday, September 1st. The shares were acquired at an average price of $4.72 per share, with a total value of $100,536.00. Following the completion of the transaction, the director owned 198,401 shares of the company's stock, valued at $936,452.72. The trade was a 12.03% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Lloyd EVP, Chief Mining Officer, & Director bought 20,000 shares of the business's stock in a transaction that occurred on Tuesday, September 1st. The shares were bought at an average price of $4.63 per share, with a total value of $92,600.00. Following the completion of the purchase, the executive vice president owned 932,881 shares in the company, valued at approximately $4,319,239.03. The trade was a 2.19% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last three months, insiders acquired 62,700 shares of company stock valued at $298,592. 5.50% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. BlackRock Inc. bought a new position in United States Antimony in the second quarter worth $82,365,000. Marshall Wace LLP boosted its stake in United States Antimony by 228.0% during the third quarter. Marshall Wace LLP now owns 3,954,186 shares of the company's stock worth $16,489,000 after buying an additional 2,748,800 shares in the last quarter. Bank of America Corp DE acquired a new stake in United States Antimony during the second quarter worth $4,208,000. Fifth Third Bancorp increased its holdings in United States Antimony by 23.8% in the 3rd quarter. Fifth Third Bancorp now owns 494,996 shares of the company's stock valued at $2,064,000 after buying an additional 95,216 shares during the period. Finally, Bank of New York Mellon Corp bought a new stake in United States Antimony in the 2nd quarter valued at $2,871,000. Institutional investors own 9.49% of the company's stock.

United States Antimony News Roundup

Investors following UAMY have been watching these news items:

• Positive Sentiment: Third-quarter revenue rose 16% year over year, to $10.13 million, providing evidence of top-line growth. Read More.
• Neutral Sentiment: HC Wainwright kept its Buy rating but cut its price target from $9.25 to $6.50. The revised target still indicates substantial potential upside from the cited $3.12 price, but the reduction reflects a more cautious outlook. Read More.
• Negative Sentiment: UAMY reported a third-quarter loss of $0.06 per share, wider than the $0.02 loss analysts expected and the $0.04 loss a year earlier. Revenue also missed estimates, while the company’s withdrawal of guidance added uncertainty. These factors were cited in reports of an overnight share decline. Read More. · Read More.

About United States Antimony

United States Antimony Corporation mines, processes and sells antimony and related products. Its offerings include antimony oxide, antimony metal and sodium antimonate, materials used in a range of industrial applications. The company also produces zeolite through its Bear River Zeolite operations in Idaho. Zeolite products are used in applications such as water treatment, agriculture and odor control. Founded in 1968, United States Antimony has processing operations in Montana and Mexico, as well as zeolite operations in Idaho.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.